LLY logo

Eli Lilly and Company (LLY) Cash From Financing

Annual CFF:

$1.23B-$2.27B(-64.81%)
December 31, 2024

Summary

  • As of today, LLY annual cash from financing is $1.23 billion, with the most recent change of -$2.27 billion (-64.81%) on December 31, 2024.
  • During the last 3 years, LLY annual cash from financing has risen by +$5.36 billion (+129.78%).
  • LLY annual cash from financing is now -64.81% below its all-time high of $3.50 billion, reached on December 31, 2023.

Performance

LLY Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherLLYcash flow metrics

Quarterly CFF:

-$1.24B-$2.62B(-190.23%)
June 30, 2025

Summary

  • As of today, LLY quarterly cash from financing is -$1.24 billion, with the most recent change of -$2.62 billion (-190.23%) on June 30, 2025.
  • Over the past year, LLY quarterly cash from financing has dropped by -$2.80 billion (-180.03%).
  • LLY quarterly cash from financing is now -128.97% below its all-time high of $4.30 billion, reached on December 31, 2008.

Performance

LLY Quarterly Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherLLYcash flow metrics

TTM CFF:

$120.70M-$2.80B(-95.87%)
June 30, 2025

Summary

  • As of today, LLY TTM cash from financing is $120.70 million, with the most recent change of -$2.80 billion (-95.87%) on June 30, 2025.
  • Over the past year, LLY TTM cash from financing has dropped by -$5.24 billion (-97.75%).
  • LLY TTM cash from financing is now -97.75% below its all-time high of $5.36 billion, reached on June 30, 2024.

Performance

LLY TTM Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherLLYcash flow metrics

Cash From Financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

LLY Cash From Financing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year-64.8%-180.0%-97.8%
3Y3 Years+129.8%-906.4%+102.4%
5Y5 Years+152.9%+25.6%+104.1%

LLY Cash From Financing Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-64.8%+122.8%-135.1%+1.5%-97.8%+102.1%
5Y5-Year-64.8%+122.8%-135.1%+56.8%-97.8%+102.0%
All-TimeAll-Time-64.8%+120.8%-129.0%+67.8%-97.8%+102.0%

LLY Cash From Financing History

DateAnnualQuarterlyTTM
Jun 2025
-
-$1.24B(-190.2%)
$120.70M(-95.9%)
Mar 2025
-
$1.38B(+712.1%)
$2.92B(+137.5%)
Dec 2024
$1.23B(-64.8%)
-$225.40M(-206.7%)
$1.23B(-75.4%)
Sep 2024
-
$211.30M(-86.4%)
$5.00B(-6.7%)
Jun 2024
-
$1.56B(+599.7%)
$5.36B(+93.4%)
Mar 2024
-
-$311.30M(-108.8%)
$2.77B(-20.7%)
Dec 2023
$3.50B(+164.7%)
$3.54B(+519.7%)
$3.50B(+393.6%)
Sep 2023
-
$572.00M(+155.4%)
-$1.19B(+60.7%)
Jun 2023
-
-$1.03B(-350.6%)
-$3.03B(-43.0%)
Mar 2023
-
$412.30M(+136.1%)
-$2.12B(+60.9%)
Dec 2022
-$5.41B(-30.9%)
-$1.14B(+9.6%)
-$5.41B(+6.6%)
Sep 2022
-
-$1.26B(-921.3%)
-$5.79B(-16.0%)
Jun 2022
-
-$123.70M(+95.7%)
-$4.99B(+16.1%)
Mar 2022
-
-$2.88B(-88.6%)
-$5.95B(-44.1%)
Dec 2021
-$4.13B(-31.7%)
-$1.53B(-229.6%)
-$4.13B(-6.0%)
Sep 2021
-
-$463.20M(+57.2%)
-$3.90B(-5.0%)
Jun 2021
-
-$1.08B(-2.3%)
-$3.71B(+13.7%)
Mar 2021
-
-$1.06B(+18.0%)
-$4.30B(-37.1%)
Dec 2020
-$3.14B(-35.0%)
-$1.29B(-362.7%)
-$3.14B(-6.0%)
Sep 2020
-
-$279.10M(+83.3%)
-$2.96B(+32.3%)
Jun 2020
-
-$1.67B(-1668.1%)
-$4.37B(-22.0%)
Mar 2020
-
$106.70M(+109.6%)
-$3.59B(-54.3%)
Dec 2019
-$2.32B(+60.6%)
-$1.11B(+34.2%)
-$2.32B(+18.5%)
Sep 2019
-
-$1.69B(-91.1%)
-$2.85B(-293.2%)
Jun 2019
-
-$885.80M(-164.8%)
-$725.00M(-8.1%)
Mar 2019
-
$1.37B(+183.4%)
-$670.60M(+88.6%)
Dec 2018
-$5.90B(-4240.9%)
-$1.64B(-478.9%)
-$5.90B(-22.8%)
Sep 2018
-
$432.70M(+152.0%)
-$4.81B(-1.4%)
Jun 2018
-
-$831.40M(+78.5%)
-$4.74B(-66.4%)
Mar 2018
-
-$3.87B(-613.0%)
-$2.85B(-2097.3%)
Dec 2017
$142.60M(+125.5%)
-$542.30M(-208.3%)
$142.60M(-85.1%)
Sep 2017
-
$500.70M(-52.8%)
$959.70M(+792.4%)
Jun 2017
-
$1.06B(+221.0%)
-$138.60M(+77.6%)
Mar 2017
-
-$875.70M(-418.7%)
-$619.10M(-10.6%)
Dec 2016
-$559.80M(+80.8%)
$274.80M(+146.0%)
-$559.80M(+63.0%)
Sep 2016
-
-$597.60M(-203.1%)
-$1.51B(-0.2%)
Jun 2016
-
$579.40M(+171.0%)
-$1.51B(+50.2%)
Mar 2016
-
-$816.40M(-20.1%)
-$3.03B(-3.9%)
Dec 2015
-$2.92B(-3787.1%)
-$679.60M(-14.2%)
-$2.92B(-377.6%)
Sep 2015
-
-$595.20M(+36.9%)
-$611.20M(-44.9%)
Jun 2015
-
-$943.20M(-34.5%)
-$421.90M(-132.8%)
Mar 2015
-
-$701.20M(-143.1%)
-$181.20M(-141.3%)
Dec 2014
-$75.10M(+98.0%)
$1.63B(+501.2%)
-$75.10M(+97.3%)
Sep 2014
-
-$405.90M(+42.2%)
-$2.74B(+4.3%)
Jun 2014
-
-$702.50M(-18.0%)
-$2.86B(-6.3%)
Mar 2014
-
-$595.10M(+42.6%)
-$2.69B(+29.6%)
Dec 2013
-$3.83B(+13.4%)
-$1.04B(-95.9%)
-$3.83B(+5.6%)
Sep 2013
-
-$529.00M(+0.9%)
-$4.06B(+0.4%)
Jun 2013
-
-$533.80M(+69.1%)
-$4.07B(+0.5%)
Mar 2013
-
-$1.73B(-36.7%)
-$4.09B(+7.4%)
Dec 2012
-$4.42B(-86.5%)
-$1.27B(-132.3%)
-$4.42B(-16.1%)
Sep 2012
-
-$544.70M(+1.4%)
-$3.81B(-2.8%)
Jun 2012
-
-$552.70M(+73.1%)
-$3.70B(+0.3%)
Mar 2012
-
-$2.06B(-216.0%)
-$3.71B(-56.7%)
Dec 2011
-$2.37B(-17.2%)
-$650.90M(-47.6%)
-$2.37B(-4.5%)
Sep 2011
-
-$440.90M(+21.9%)
-$2.27B(-2.1%)
Jun 2011
-
-$564.30M(+20.9%)
-$2.22B(-1.5%)
Mar 2011
-
-$713.80M(-29.9%)
-$2.19B(-8.2%)
Dec 2010
-$2.02B(+63.5%)
-$549.60M(-39.6%)
-$2.02B(+22.3%)
Sep 2010
-
-$393.80M(+25.9%)
-$2.60B(+16.6%)
Jun 2010
-
-$531.50M(+2.8%)
-$3.12B(+15.7%)
Mar 2010
-
-$547.00M(+51.5%)
-$3.70B(+33.1%)
Dec 2009
-$5.53B(-335.9%)
-$1.13B(-23.6%)
-$5.53B(-5023.8%)
Sep 2009
-
-$913.20M(+17.8%)
-$108.00M(-145.1%)
Jun 2009
-
-$1.11B(+53.3%)
$239.40M(-71.1%)
Mar 2009
-
-$2.38B(-155.4%)
$827.50M(-64.7%)
Dec 2008
$2.35B(+377.7%)
$4.30B(+859.5%)
$2.35B(+196.1%)
Sep 2008
-
-$565.80M(-8.1%)
-$2.44B(+0.3%)
Jun 2008
-
-$523.50M(+39.3%)
-$2.45B(+7.6%)
Mar 2008
-
-$861.90M(-75.6%)
-$2.65B(-213.7%)
Dec 2007
-$844.90M(+81.5%)
-$490.70M(+14.4%)
-$844.90M(+56.9%)
Sep 2007
-
-$573.20M(+20.9%)
-$1.96B(+40.5%)
Jun 2007
-
-$724.60M(-176.8%)
-$3.29B(-9.9%)
Mar 2007
-
$943.60M(+158.8%)
-$2.99B(+34.6%)
Dec 2006
-$4.58B
-$1.60B(+15.8%)
-$4.58B(-22.9%)
Sep 2006
-
-$1.91B(-345.9%)
-$3.73B(-1212.1%)
DateAnnualQuarterlyTTM
Jun 2006
-
-$427.50M(+33.2%)
-$284.00M(-20.5%)
Mar 2006
-
-$640.30M(+14.9%)
-$235.70M(+87.5%)
Dec 2005
-$1.88B(-1023.2%)
-$752.60M(-149.0%)
-$1.88B(-63.5%)
Sep 2005
-
$1.54B(+505.2%)
-$1.15B(+44.9%)
Jun 2005
-
-$379.20M(+83.4%)
-$2.09B(+0.6%)
Mar 2005
-
-$2.29B(>-9900.0%)
-$2.10B(-1130.9%)
Dec 2004
$203.70M(+112.9%)
-$22.30M(-103.7%)
$203.70M(+153.0%)
Sep 2004
-
$600.00M(+252.9%)
-$384.00M(+63.5%)
Jun 2004
-
-$392.50M(-2221.6%)
-$1.05B(+13.4%)
Mar 2004
-
$18.50M(+103.0%)
-$1.22B(+22.9%)
Dec 2003
-$1.58B(-274.0%)
-$610.00M(-781.5%)
-$1.58B(+11.8%)
Sep 2003
-
-$69.20M(+87.6%)
-$1.79B(-75.8%)
Jun 2003
-
-$556.00M(-62.1%)
-$1.02B(-14.6%)
Mar 2003
-
-$343.10M(+58.2%)
-$888.60M(-110.6%)
Dec 2002
-$422.00M(+59.8%)
-$820.70M(-216.9%)
-$422.00M(-300.0%)
Sep 2002
-
$701.90M(+264.5%)
-$105.50M(+89.3%)
Jun 2002
-
-$426.70M(-445.5%)
-$986.60M(-55.7%)
Mar 2002
-
$123.50M(+124.5%)
-$633.80M(+39.6%)
Dec 2001
-$1.05B(+53.0%)
-$504.20M(-181.4%)
-$1.05B(+3.3%)
Sep 2001
-
-$179.20M(-142.5%)
-$1.08B(+25.2%)
Jun 2001
-
-$73.90M(+74.6%)
-$1.45B(+21.6%)
Mar 2001
-
-$291.40M(+46.0%)
-$1.85B(+17.1%)
Dec 2000
-$2.23B(-53.5%)
-$539.50M(+0.8%)
-$2.23B(-3.8%)
Sep 2000
-
-$543.90M(-15.1%)
-$2.15B(-81.2%)
Jun 2000
-
-$472.40M(+29.9%)
-$1.19B(+26.1%)
Mar 2000
-
-$673.70M(-47.2%)
-$1.60B(-10.4%)
Dec 1999
-$1.45B(+48.4%)
-$457.80M(-209.4%)
-$1.45B(+27.2%)
Sep 1999
-
$418.40M(+147.0%)
-$1.99B(+30.9%)
Jun 1999
-
-$890.70M(-70.4%)
-$2.88B(-8.6%)
Mar 1999
-
-$522.60M(+47.7%)
-$2.66B(+5.6%)
Dec 1998
-$2.81B(-43.9%)
-$999.20M(-112.0%)
-$2.81B(-37.1%)
Sep 1998
-
-$471.40M(+28.9%)
-$2.05B(+13.1%)
Jun 1998
-
-$662.60M(+2.5%)
-$2.36B(+9.6%)
Mar 1998
-
-$679.50M(-186.2%)
-$2.61B(-33.6%)
Dec 1997
-$1.95B(-17.7%)
-$237.40M(+69.6%)
-$1.95B(+11.7%)
Sep 1997
-
-$781.30M(+14.5%)
-$2.21B(-1.9%)
Jun 1997
-
-$913.50M(-3978.1%)
-$2.17B(-36.0%)
Mar 1997
-
-$22.40M(+95.5%)
-$1.60B(+3.8%)
Dec 1996
-$1.66B(-104.1%)
-$496.50M(+32.9%)
-$1.66B(-1.5%)
Sep 1996
-
-$739.50M(-118.2%)
-$1.64B(-38.6%)
Jun 1996
-
-$338.90M(-293.2%)
-$1.18B(-8.6%)
Mar 1996
-
-$86.20M(+81.7%)
-$1.09B(-33.7%)
Dec 1995
-$813.70M(-128.7%)
-$472.30M(-66.5%)
-$813.70M(-132.4%)
Sep 1995
-
-$283.60M(-15.4%)
$2.51B(-5.9%)
Jun 1995
-
-$245.80M(-230.7%)
$2.67B(-9.3%)
Mar 1995
-
$188.00M(-93.4%)
$2.94B(+3.8%)
Dec 1994
$2.84B(+642.4%)
$2.86B(+2348.6%)
$2.84B(+1297.2%)
Sep 1994
-
-$127.00M(-563.5%)
-$237.00M(+38.0%)
Jun 1994
-
$27.40M(-66.3%)
-$382.20M(+41.6%)
Mar 1994
-
$81.20M(+137.1%)
-$654.10M(-25.0%)
Dec 1993
-$523.10M(+11.1%)
-$218.60M(+19.7%)
-$523.10M(+33.6%)
Sep 1993
-
-$272.20M(-11.3%)
-$788.20M(-55.9%)
Jun 1993
-
-$244.50M(-215.2%)
-$505.70M(-55.4%)
Mar 1993
-
$212.20M(+143.9%)
-$325.40M(+44.7%)
Dec 1992
-$588.60M(-111.6%)
-$483.70M(-4796.1%)
-$588.60M(-97.8%)
Sep 1992
-
$10.30M(+116.0%)
-$297.60M(+40.6%)
Jun 1992
-
-$64.20M(-25.9%)
-$500.90M(-46.7%)
Mar 1992
-
-$51.00M(+73.5%)
-$341.40M(-22.7%)
Dec 1991
-$278.20M(+29.3%)
-$192.70M(+0.2%)
-$278.20M(-25.1%)
Sep 1991
-
-$193.00M(-302.5%)
-$222.30M(-40.3%)
Jun 1991
-
$95.30M(+681.1%)
-$158.50M(+52.6%)
Mar 1991
-
$12.20M(+108.9%)
-$334.70M(+15.0%)
Dec 1990
-$393.70M(+26.9%)
-$136.80M(-5.9%)
-$393.70M(-53.3%)
Sep 1990
-
-$129.20M(-59.7%)
-$256.90M(-101.2%)
Jun 1990
-
-$80.90M(-72.9%)
-$127.70M(-172.9%)
Mar 1990
-
-$46.80M
-$46.80M
Dec 1989
-$538.30M(+20.0%)
-
-
Dec 1988
-$672.60M(-44.3%)
-
-
Dec 1987
-$466.00M(-6.4%)
-
-
Dec 1986
-$438.10M(-45.4%)
-
-
Dec 1985
-$301.40M(-4.6%)
-
-
Dec 1984
-$288.20M(-10.1%)
-
-
Dec 1983
-$261.70M(-50.7%)
-
-
Dec 1982
-$173.66M(-11.5%)
-
-
Dec 1981
-$155.74M(+8.3%)
-
-
Dec 1980
-$169.78M
-
-

FAQ

  • What is Eli Lilly and Company annual cash from financing?
  • What is the all-time high annual cash from financing for Eli Lilly and Company?
  • What is Eli Lilly and Company annual cash from financing year-on-year change?
  • What is Eli Lilly and Company quarterly cash from financing?
  • What is the all-time high quarterly cash from financing for Eli Lilly and Company?
  • What is Eli Lilly and Company quarterly cash from financing year-on-year change?
  • What is Eli Lilly and Company TTM cash from financing?
  • What is the all-time high TTM cash from financing for Eli Lilly and Company?
  • What is Eli Lilly and Company TTM cash from financing year-on-year change?

What is Eli Lilly and Company annual cash from financing?

The current annual cash from financing of LLY is $1.23B

What is the all-time high annual cash from financing for Eli Lilly and Company?

Eli Lilly and Company all-time high annual cash from financing is $3.50B

What is Eli Lilly and Company annual cash from financing year-on-year change?

Over the past year, LLY annual cash from financing has changed by -$2.27B (-64.81%)

What is Eli Lilly and Company quarterly cash from financing?

The current quarterly cash from financing of LLY is -$1.24B

What is the all-time high quarterly cash from financing for Eli Lilly and Company?

Eli Lilly and Company all-time high quarterly cash from financing is $4.30B

What is Eli Lilly and Company quarterly cash from financing year-on-year change?

Over the past year, LLY quarterly cash from financing has changed by -$2.80B (-180.03%)

What is Eli Lilly and Company TTM cash from financing?

The current TTM cash from financing of LLY is $120.70M

What is the all-time high TTM cash from financing for Eli Lilly and Company?

Eli Lilly and Company all-time high TTM cash from financing is $5.36B

What is Eli Lilly and Company TTM cash from financing year-on-year change?

Over the past year, LLY TTM cash from financing has changed by -$5.24B (-97.75%)
On this page